Twin.. my thoughts exactly and i suspect the Ferghana appointment may have something to do with this.. but that is just a gut feel as i think someone ADO has done some work for may have put an offer on the table recently.. ADO partnering to become a fully fledged assay developer???... and one that can deliver results almost instantly with the tech and with a little more time to tweak it .. deliver what others may never have been able to.. once word got around that would make for a long waiting list imo of shelved assays that were once thought not possible and have been sitting in the too hard or not possible basket!!..
Who could they partner with.. ??? well thats the million $$ question.. i have a few in mind .. as im sure you do ..
POC handheld multiplex devices are a hot topic right now and all the big boys are looking to break into this market first with a commercially stable product to capitilise early on gaining market share first.... if i was POC1 or BBI i know i would be looking at locking something in with ADO on a more concrete basis .. ADO could actually service both quite nicely initially imo as they are not YET in competing markets ie. handheld POC vs lateral flow.. well ... that would put ADO in quite a sort after imvho.. just needs ink to paper.. the rest will be history..
Its free to dream.. so i dream a lot.. up to now the dream seems to be playing out slowly but surely.. lets hope it continues
ADO Price at posting:
18.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)